| Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients JD Barros-Silva, D Leitao, L Afonso, J Vieira, M Dinis-Ribeiro, M Fragoso, ... British journal of cancer 100 (3), 487-493, 2009 | 259 | 2009 |
| FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer P Paulo, JD Barros‐Silva, FR Ribeiro, J Ramalho‐Carvalho, C Jerónimo, ... Genes, Chromosomes and Cancer 51 (3), 240-249, 2012 | 110 | 2012 |
| Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements P Paulo, FR Ribeiro, J Santos, D Mesquita, M Almeida, JD Barros-Silva, ... Neoplasia 14 (7), 600-IN15, 2012 | 109 | 2012 |
| Single-cell analysis identifies LY6D as a marker linking castration-resistant prostate luminal cells to prostate progenitors and cancer JD Barros-Silva, DE Linn, I Steiner, G Guo, A Ali, H Pakula, G Ashton, ... Cell reports 25 (12), 3504-3518. e6, 2018 | 83 | 2018 |
| Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing’s sarcoma and prostate carcinoma MJ Camoes, P Paulo, FR Ribeiro, JD Barros-Silva, M Almeida, VL Costa, ... PloS one 7 (11), e49819, 2012 | 66 | 2012 |
| Radiosensitising cancer using phosphatidylinositol-3-kinase (PI3K), protein kinase B (AKT) or mammalian target of rapamycin (mTOR) inhibitors K Wanigasooriya, R Tyler, JD Barros-Silva, Y Sinha, T Ismail, AD Beggs Cancers 12 (5), 1278, 2020 | 63 | 2020 |
| Novel 5′ fusion partners of ETV1 and ETV4 in prostate cancer JD Barros-Silva, P Paulo, AC Bakken, N Cerveira, M Løvf, R Henrique, ... Neoplasia 15 (7), 720-IN6, 2013 | 58 | 2013 |
| Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation A Gusev, H Shi, G Kichaev, M Pomerantz, F Li, HW Long, SA Ingles, ... Nature communications 7 (1), 10979, 2016 | 57 | 2016 |
| Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene FR Ribeiro, P Paulo, VL Costa, JD Barros-Silva, J Ramalho-Carvalho, ... PloS one 6 (7), e22317, 2011 | 56 | 2011 |
| Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts D Mesquita, JD Barros-Silva, J Santos, RI Skotheim, RA Lothe, P Paulo, ... Oncotarget 6 (7), 5217, 2015 | 51 | 2015 |
| Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies J Vieira, R Henrique, FR Ribeiro, JD Barros‐Silva, A Peixoto, C Santos, ... Genes, Chromosomes and Cancer 49 (10), 935-947, 2010 | 47 | 2010 |
| Relative 8q gain predicts disease‐specific survival irrespective of the TMPRSS2‐ERG fusion status in diagnostic biopsies of prostate cancer JD Barros‐Silva, FR Ribeiro, A Rodrigues, R Cruz, AT Martins, ... Genes, Chromosomes and Cancer 50 (8), 662-671, 2011 | 45 | 2011 |
| Altered Expression of MGMT in High-Grade Gliomas Results from the Combined Effect of Epigenetic and Genetic Aberrations J Ramalho-Carvalho, M Pires, S Lisboa, I Graca, P Rocha, ... PLoS One 8 (3), e58206, 2013 | 44 | 2013 |
| Genomic evaluation of multiparametric magnetic resonance imaging-visible and-nonvisible lesions in clinically localised prostate cancer MA Parry, S Srivastava, A Ali, A Cannistraci, J Antonello, JD Barros-Silva, ... European urology oncology 2 (1), 1-11, 2019 | 41 | 2019 |
| Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution N Cerveira, S Lisboa, C Correia, S Bizarro, J Santos, L Torres, J Vieira, ... Molecular oncology 6 (5), 553-564, 2012 | 36 | 2012 |
| Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing T Nome, GOS Thomassen, J Bruun, T Ahlquist, AC Bakken, AM Hoff, ... Translational Oncology 6 (5), 546-IN5, 2013 | 35 | 2013 |
| Deregulation of PAX 2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis P Patrício, J Ramalho‐Carvalho, P Costa‐Pinheiro, M Almeida, ... Journal of Cellular and Molecular Medicine 17 (8), 1048-1058, 2013 | 27 | 2013 |
| Patient derived organoids confirm that PI3K/AKT signalling is an escape pathway for radioresistance and a target for therapy in rectal cancer K Wanigasooriya, JD Barros-Silva, L Tee, ME El-Asrag, A Stodolna, ... Frontiers in oncology 12, 920444, 2022 | 21 | 2022 |
| Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements J Santos, D Mesquita, JD Barros-Silva, C Jerónimo, R Henrique, A Morais, ... Oncoscience 2 (5), 497, 2015 | 21 | 2015 |
| NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer MP Silva, JD Barros‐Silva, J Vieira, S Lisboa, L Torres, C Correia, ... Genes, Chromosomes and Cancer 55 (4), 365-374, 2016 | 19 | 2016 |
Rolf I. SkotheimDept. Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitaletuio.no üzerinde doğrulanmış e-posta adresine sahip
